1262860-72-9

Usage

Uses

Used in Pharmaceutical Industry:
3-Chloro-5-difluoroMethoxy-pyridine-2-carboxylic acid is used as a key intermediate for the synthesis of various pharmaceuticals, leveraging its reactive nature and structural diversity to contribute to the development of novel therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Chloro-5-difluoroMethoxy-pyridine-2-carboxylic acid is utilized as a building block for the creation of new agrochemicals, enhancing crop protection and management through innovative chemical compounds.
Used in Medicinal Chemistry Research:
3-Chloro-5-difluoroMethoxy-pyridine-2-carboxylic acid is employed as a versatile precursor in medicinal chemistry, facilitating the exploration and synthesis of complex organic compounds for potential drug candidates.
Used in Drug Discovery:
This chemical compound is used in drug discovery processes, serving as a starting material for the development of new drugs, thanks to its unique molecular structure and reactivity.
Overall, 3-Chloro-5-difluoroMethoxy-pyridine-2-carboxylic acid's multifaceted applications across different industries underscore its importance in the advancement of chemical sciences and healthcare solutions.

Upstream product

• 98121-41-6 5-Amino-2,3-dichloropyridine 
• 1262860-73-0 3-chloro-5-(difluoromethoxy)pyridine-2-carbonitrile 
• 110861-18-2 5-acetoxy-2,3-dichloropyridine 
• 1262860-70-7 3-chloro-5-hydroxy-pyridine-2-carbonitrile 

Relevant academic research and scientific papers

N-[2-(3-AMINO-2,5-DIMETHYL-1,1-DIOXIDO-5,6-DIHYDRO-2H-1,2,4-THIADIAZIN-5-YL)-1,3-THIAZOL-4-YL] AMIDES USEFUL AS BACE INHIBITORS

The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2 and R3/su

TETRAHYDROPYRANO[3,4-D][1,3]OXAZIN DERIVATIVES AND THEIR USE AS BACE INHIBITORS

The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula (I), wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

N-[2-(2-AMINO-6,6-DISUBSTITUTED-4, 4A, 5, 6-TETRAHYDROPYRANO [3,4-D][1,3] THIAZIN-8A (8H)-YL) -1, 3-THIAZOL-4-YL] AMIDES

The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula (I), and the variables R1, R2 and R3

OXAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS

The invention relates to novel heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification, in free form or in pharmaceutically acceptable salt form, to their preparation, to their medical use and to medicaments comprising them.

Oxazine derivatives and their use in the treatment of neurological disorders

The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their medical use and to medicaments comprising them.

Oxazine Derivatives and their Use in the Treatment of Neurological Disorders

The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their medical use and to medicaments comprising them.